Immunity from “Sputnik V” can be maintained for two years – E. Kiyasov
According to one of the world’s leading medical journals Lancet, the effectiveness of the Russian vaccine against coronavirus infection “Sputnik V” is 91.6%, and immunity after vaccination can last up to two years. This was announced today by the Vice Minister of Health – Chief State Sanitary Doctor Yerlan Kiyasov.
“Just yesterday, one of the world’s leading medical scientific journals, Lancet (UK), reported that the effectiveness of the vaccine against infection with the SARS-CoV-2 coronavirus was 91.6%. In addition, it has been proven that immunity after Sputnik can persist for at least two years. It is especially important that the vaccine is also effective against new strains of coronavirus: “British” and “South African”. Also, the developers of the vaccine emphasize that Sputnik 100% protects against moderate and severe Covid-19, “said E. Kiyasov.
The vice minister recalled that vaccination in the Republic of Kazakhstan started on February 1 and will be carried out in stages, taking into account the receipt of the vaccine and the epidemiological significance of various groups of the population.
First of all, it will cover medical workers of infectious diseases hospitals, emergency medical care, and also other profiles. Further, teachers and employees of law enforcement agencies will be connected to the group of subjects with a further expansion of the contingent of vaccinated as the amount of vaccine is sufficient.
The Ministry of Health has developed Guidelines for organizing and conducting vaccination against CVI and the Regulations for the storage and transportation of vaccines for the prevention of COVID for all participants in the cold chain. According to 18 subparagraph 77 of article of the Code of the Republic of Kazakhstan “On people’s health and the health care system”, vaccination against CVI will be carried out only with informed consent for vaccination and free of charge from the state budget.
“In case of adverse consequences after receiving the vaccine, responsibility will be borne by all participants in the process: from the manufacturer, ending directly with medical institutions. In addition, expert groups have been created at public health departments in the regions, which include specialized specialists. In case of manifestation of adverse consequences, these commissions will conduct an investigation, and further measures will be taken in accordance with the legislation of the Republic of Kazakhstan, “E. Kiyasov assured.